AbdiBio Production Facility

THE LARGEST BIOTECHNOLOGICAL PHARMACEUTICALS MANUFACTURING FACILITY OF TURKEY: ABDİBİO

Abdi İbrahim made an investment of $100 million to manufacture biotechnological pharmaceuticals for Turkey, which meets almost the entirety of its demand with imports today. Turkey's largest biotechnological production facility AbdiBio’s foundations were laid in 2015 and inauguration ceremony was held on 11th of May 2018.

All manufacturing processes from cell bank to end product will be implemented in this new facility. AbdiBio will produce biotechnological medicines for cancer, diabetes, rheumatism, as well as central nervous system, blood, gastroanterological, dermatological and immunological diseases.
The biotechnological medicines produced in AbdiBio will be used in Turkey and abroad. Contract manufacturing servises for different companies will also be provided.

With biotechnological researches in AbdiBio, Abdi İbrahim will help heal more lives in:
• Hematology
• Oncology
• Rheumatology
• Immunology
• Endocrinology
• Neurology
• Dermatology
• Gastroenterology
• Ophthalmology

SITE MAP
INFORMATION SOCIETY SERVICES
© 2016-2018 Abdi İbrahim İlaç Sanayi ve Tic A.Ş.
The information provided on this site is not intended as an advice. Information provided should be discussed with your healthcare professional.
Phone: 0212 366 8400
E-Mail: info@abdiibrahim.com.tr